All Work
SEPTEMBER 25, 2024
Inclusive design reduces the need for special accommodations, promoting a welcoming environment that leverages the strengths of diverse talents, ultimately leading to better decision-making, higher-quality work, and greater team satisfaction. This article was written by Ballinger ’s Kate Hallinan for Work Design Magazine.
Vantage Circle
MAY 10, 2021
All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. With the constant layoffs, corporate mergers and acquisitions in the pharmaceutical market, and rise in the compensation standards, many businesses have also adopted an outsourcing business model. Development in Technology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Work Life
DECEMBER 14, 2023
Pharmaceutical Pharmaceutical companies have had a difficult year: the industry is grappling with softening demand for COVID-19-related products. And many small to midsize pharmaceuticals are still looking for funding and partnerships to move their products forward in clinical trials.
People Business Psychology
DECEMBER 5, 2024
A pharmaceutical company might state that “promoting health” is one of their key values, and a cinema or theatre chain might espouse the value of entertainment and leisure. Value-Based Decision Making: Encourage leaders to make decisions based on the organization’s values, demonstrating their importance in everyday actions.
Mad in America
NOVEMBER 7, 2023
In other words, the decision-making begins with the provider, not the patient. To partially reverse this sequence of events in favor of greater patient involvement, multiple groups have advocated a process referred to as Shared Decision-Making (SDM) (including Britain’s National Health Service, in their most recent guidelines.
McKensey
MARCH 21, 2025
To compete in an increasingly complex market, companies will need to unleash distinctive capabilities, reduce low-value work, speed up decision-making, and harness AI and digital.
Mad in America
OCTOBER 31, 2023
Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. This notable gap has raised some suspicion that the necessary research has not merely been overlooked but deliberately avoided.
Expert insights. Personalized for you.
215 
Let's personalize your content